Global Oxygen Therapy market Overview:
According to SPER Market Research, the Oxygen Therapy Market is estimated to reach USD 55.59 billion by 2030 with a CAGR of 5.8%.
A medical procedure known as oxygen therapy, sometimes known as supplementary oxygen, includes utilising an extra oxygen source to control blood oxygen levels and avoid carbon monoxide poisoning. It is frequently used for ailments like hypoxia, hypoxemia, pneumonia, and asthma. Liquid or gaseous oxygen is provided, and it is delivered by a cannula, face mask, or hyperbaric oxygen chamber. In order to increase the effectiveness of the treatment, they are also connected to other medical devices including ventilators and continuous positive airway pressure machines. To give patients with point-of-care (POC) and practical oxygen therapy treatments, healthcare facilities are also utilising cutting-edge portable tanks and oxygen concentrators.
One of the main reasons contributing to a good prognosis for the market growth is the rising incidence of several respiratory ailments, such as pneumonia, cystic fibrosis, asthma, dysplasia, and sleep apnea, throughout the world. Improved oxygen transport from alveoli to blood, cell metabolism, and tissue oxygenation are all benefits of oxygen treatment. These processes are necessary for healthy physiological function. A further factor driving the market's expansion is the expanding senior population, which is more prone to illnesses like these, combined with increased nicotine and tobacco product usage. A bright outlook for the market is also being created by the development of affordable, quick, and accurate oxygen treatment equipment as well as the growing desire for oxygen therapy among doctors, surgeons, and patients.
This market is anticipated to develop as a result of a variety of factors, including the rising frequency of respiratory illnesses, the aging population's rapid increase, the high prevalence of tobacco use, the demand for home-based oxygen therapy, and technical improvements.
Market growth is anticipated to be somewhat constrained by the availability of inexpensive replacements made by local manufacturers, strict regulatory requirements that cause delays in product approvals, and Medicare payment rate reductions for home oxygen treatment in the United States.
Major market participants in the oxygen therapy equipment market have recently introduced novel items, and they have plans to do the same in the future, as well as grow geographically and introduce new products.
Due to its high availability and use in the form of O2 concentrators, compressed gas systems, cylinders, and liquid oxygen, oxygen source equipment made up the highest percentage in 2021. Additionally, these devices serve as the main source and first step in O2 treatment, playing a crucial role in the industry's overall growth. In the oxygen source equipment market, oxygen concentrators are expected to expand at a profitable pace. Due to their use in ambulances, trains, and airplanes, as well as their application in different medical crises, transportable concentrators are anticipated to exhibit high development potential, which will help to drive this segment's prospective demand.
Additionally, the development of technologically sophisticated oxygen source and delivery technologies, which provide effective patient care, is anticipated to accelerate the industry's growth. These improvements include sensors, flow regulators, and delivery devices coupled with pulse dosage metres. O2 treatment is becoming more widely used as a result of its potential advantages, including regulated flow, effective dosage, quicker reaction times, and higher durability and dependability. We expect the aforementioned elements to fuel industry development.
Over the next several years, it is expected that demand will increase due to the growing acceptance and popularity of on-demand and continuous Portable Oxygen Concentrators (POC) in a variety of applications, including emergency medicine. This increase is linked to the entry of international rivals, consumer desire for portable technology, and the urgent clinical need for more mobility support for the senior population. The firm is expected to grow as a consequence of ongoing innovation, which produces more effective units and lower pricing.
Due to the availability of a wide range of delivery devices tailored to different patients' physiological and inspiratory demands, the oxygen delivery devices market is predicted to develop at a profitable pace.
Impact of COVID-19 on the Global Oxygen Therapy Market
As a result of lockdown regulations and supply chain management issues, the COVID-19 pandemic severely impacted the medical device sector. However, because oxygen therapy was used as the first line of treatment for critically sick patients with coronavirus infections, oxygen therapy equipment saw high demand throughout the crisis. The demand for oxygen concentrators surged as a result of a severe global ventilator shortage. Biomedical engineers and scientists have created temporary systems that imitate the essential features of ventilators utilizing existing equipment including oxygen concentrators, PAP machines, anaesthetic machines, and manual resuscitators in order to get around this scarcity.
Additionally, the Emergency Use Authorization system approved by the U.S. FDA permits the use of these concentrators, which will dramatically boost demand for oxygen concentrators in the upcoming quarters. The need for wall-mounted oxygen concentrators and canned oxygen is significantly increasing as the majority of COVID-19 serious patients necessitate some type of artificial ventilation. Additionally, the market has grown as a result of rising demand for technologically sophisticated products such portable oxygen concentrators. Pulse oximetry technology and oxygen therapy for the nasopharynx are two significant commercial breakthroughs.
Scope of the report:
| Report Metric | Details |
| Market size available for years | 2019-2030 |
| Base year considered | 2021 |
| Forecast period | 2022-2030 |
| Segments covered | By Product, By Portability, By Application, By End Use
|
| Geographies covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Covered | CAllied Healthcare Products, Inc., Andreas Fahl Medizintechnik-Vertriebs GmbH, Becton, Dickinson and Company, CAIRE, Chart Industries, Inc., DeVilbiss Healthcare Drägerwerk AG & Co. KGaA, Essex Industries, Inc., Fisher & Paykel Healthcare Corporation Limited, GCE Holding AB, GE Healthcare, Heinen + Löwenstein GmbH & Co. KG, HERSILL S.L., HUM - Gesellschaft für Homecare und Medizintechnik mbH, Inogen, Inc., Invacare Corporation, IUC Medical, Linde Healthcare, Medicap homecare GmbH, Medicop D.O.O., Messer Medical Austria GmbH, Philips Healthcare, Philips Respironics, Inc., ResMedDrägerwerk AG & Co. KGaALinde, Respan Products Inc., Smiths Medical, Taiyo Nippon Sanso Corporation, Tecno-Gaz IndustriesTeleflex Incorporated, Weinmann Emergency Medical Technology GmbH + Co. KG. |
Global Oxygen Therapy Market, By Product:
Based on the Product, Global Oxygen Therapy Market is segmented as; Oxygen Source Equipment (Oxygen Concentrators, Liquid Oxygen Devices, Oxygen Cylinders, PAP Devices), Oxygen Delivery Devices (Oxygen Masks, Nasal Cannulas, Venturi Masks, Non-rebreather Masks, Bag-valve Masks, CPAP Masks), Other Oxygen Delivery Devices.
Global Oxygen Therapy Market, By Portability:
Based on the Portability, Global Oxygen Therapy Market is segmented as; Stationary Devices and Portable Devices.
Global Oxygen Therapy Market, By Application:
Based on the Application, Global Oxygen Therapy Market is segmented as; Chronic Obstructive Pulmonary Disease (COPD), Asthma, Cystic Fibrosis, Respiratory Distress Syndrome, Pneumonia, Other Diseases.
Global Oxygen Therapy Market, By End Use:
Based on the End Use, Global Oxygen Therapy Market is segmented as; Home Healthcare, Non-Home Healthcare, Ambulatory Surgical Centers & Physician Offices.
Global Oxygen Therapy Market, By Region:
North America leads the world market, followed by Europe. Throughout the projection period, North America will continue to rule the worldwide market. However, Asia-Pacific is predicted to have the greatest CAGR, with China, Japan, and India driving this market's expansion. A few drivers driving market expansion in the APAC region include rising healthcare investment, rising healthcare spending, rising disposable incomes, and rising healthcare insurance coverage.
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1 Research data source
2.1.1 Secondary data
2.1.2 Primary data
2.1.3 SPER’s internal database
2.1.4 Premium insight from KOL’s
2.2 Market size estimation
2.2.1 Top-down and Bottom-up approach
2.3 Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2. COVID-19 Impacts of the Global Oxygen Therapy Market
5. Market variables and outlook
5.1. SWOT analysis
5.1.1 Strengths
5.1.2 Weaknesses
5.1.3 Opportunities
5.1.4 Threats
5.2. PESTEL analysis
5.2.1 Political landscape
5.2.2 Economic landscape
5.2.3 Social landscape
5.2.4 Technological landscape
5.2.5 Environmental landscape
5.2.6 Legal landscape
5.3. PORTER’S five forces analysis
5.3.1 Bargaining power of suppliers
5.3.2 Bargaining power of Buyers
5.3.3 Threat of Substitute
5.3.4 Threat of new entrant
5.3.5 Competitive rivalry
5.4. Heat map analysis
6. Global Oxygen Therapy Market, By Product, 2019-2030 (USD Million)
6.1 Oxygen Source Equipment
6.1.1 Oxygen Concentrators
6.1.2 Liquid Oxygen Devices
6.1.3 Oxygen Cylinders
6.1.4 PAP Devices
6.2 Oxygen Delivery Devices
6.2.1 Oxygen Masks
6.2.2 Nasal Cannulas
6.2.3 Venturi Masks
6.2.4 Non-rebreather Masks
6.2.5 Bag-valve Masks
6.2.6 CPAP Masks
6.2.7 Other Oxygen Delivery Devices
7. Global Oxygen Therapy Market, By Portability, 2019-2030 (USD Million)
7.1 Stationary Devices
7.2 Portable Devices
8. Global Oxygen Therapy Market, By Application, 2019-2030 (USD Million)
8.1 Chronic Obstructive Pulmonary Disease(COPD)
8.2 Asthma
8.3 Cystic Fibrosis
8.4 Respiratory Distress Syndrome
8.5 Pneumonia
8.6 Other Diseases
9. Global Oxygen Therapy Market, By End Use, 2019-2030 (USD Million)
9.1 Home Healthcare
9.2 Non-Home Healthcare
9.3 Ambulatory Surgical Centers & Physician Offices
10. Global Oxygen Therapy Market, By Region, 2019-2030 (USD Million)
10.1 North America
10.1.1 United States
10.1.2 Canada
10.1.3 Mexico
10.2 Europe
10.2.1 Germany
10.2.2 United Kingdom
10.2.3 France
10.2.4 Italy
10.2.5 Spain
10.2.6 Rest of Europe
10.3 Asia-Pacific
10.3.1 China
10.3.2 Japan
10.3.3 India
10.3.4 Australia
10.3.5 South Korea
10.3.6 Rest of Asia-Pacific
10.4 South America
10.4.1 Brazil
10.4.2 Argentina
10.4.3 Rest of South America
10.5 Middle East & Africa
10.5.1 Kingdom of Saudi Arabia
10.5.2 United Arab Emirates
10.5.3 Rest of Middle East & Africa
11. Company Profiles
11.1 Allied Healthcare Products, Inc.
11.1.1 Company details
11.1.2 Financial outlook
11.1.3 Product summary
11.1.4 Recent developments
11.2 Andreas Fahl Medizintechnik-Vertriebs GmbH
11.2.1 Company details
11.2.2 Financial outlook
11.2.3 Product summary
11.2.4 Recent developments
11.3 Becton, Dickinson and Company
11.3.1 Company details
11.3.2 Financial outlook
11.3.3 Product summary
11.3.4 Recent developments
11.4 CAIRE
11.4.1 Company details
11.4.2 Financial outlook
11.4.3 Product summary
11.4.4 Recent developments
11.5 Chart Industries, Inc.
11.5.1 Company details
11.5.2 Financial outlook
11.5.3 Product summary
11.5.4 Recent developments
11.6 DeVilbiss Healthcare
11.6.1 Company details
11.6.2 Financial outlook
11.6.3 Product summary
11.6.4 Recent developments
11.7 Drägerwerk AG & Co. KGaA
11.7.1 Company details
11.7.2 Financial outlook
11.7.3 Product summary
11.7.4 Recent developments
11.8 Essex Industries, Inc.
11.8.1 Company details
11.8.2 Financial outlook
11.8.3 Product summary
11.8.4 Recent developments
11.9 Fisher & Paykel Healthcare Corporation Limited
11.9.1 Company details
11.9.2 Financial outlook
11.9.3 Product summary
11.9.4 Recent developments
11.10 GCE Holding AB
11.10.1 Company details
11.10.2 Financial outlook
11.10.3 Product summary
11.10.4 Recent developments
11.11 GE Healthcare
11.11.1 Company details
11.11.2 Financial outlook
11.11.3 Product summary
11.11.4 Recent developments
11.12 Heinen + Löwenstein GmbH & Co. KG
11.12.1 Company details
11.12.2 Financial outlook
11.12.3 Product summary
11.12.4 Recent developments
11.13 HERSILL S.L.
11.13.1 Company details
11.13.2 Financial outlook
11.13.3 Product summary
11.13.4 Recent developments
11.14 HUM - Gesellschaft für Homecare und Medizintechnik mbH
11.14.1 Company details
11.14.2 Financial outlook
11.14.3 Product summary
11.14.4 Recent developments
11.15 Inogen, Inc.
11.15.1 Company details
11.15.2 Financial outlook
11.15.3 Product summary
11.15.4 Recent developments
11.16 Invacare Corporation
11.16.1 Company details
11.16.2 Financial outlook
11.16.3 Product summary
11.16.4 Recent developments
11.17 IUC Medical
11.17.1 Company details
11.17.2 Financial outlook
11.17.3 Product summary
11.17.4 Recent developments
11.18 Linde Healthcare
11.18.1 Company details
11.18.2 Financial outlook
11.18.3 Product summary
11.18.4 Recent developments
11.19 Medicap homecare GmbH
11.19.1 Company details
11.19.2 Financial outlook
11.19.3 Product summary
11.19.4 Recent developments
11.20 Medicop D.O.O.
11.20.1 Company details
11.20.2 Financial outlook
11.20.3 Product summary
11.20.4 Recent developments
11.21 Messer Medical Austria GmbH
11.21.1 Company details
11.21.2 Financial outlook
11.21.3 Product summary
11.21.4 Recent developments
11.22 Philips Healthcare
11.22.1 Company details
11.22.2 Financial outlook
11.22.3 Product summary
11.22.4 Recent developments
11.23 Philips Respironics, Inc.
11.23.1 Company details
11.23.2 Financial outlook
11.23.3 Product summary
11.23.4 Recent developments
11.24 ResMedDrägerwerk AG & Co. KGaALinde
11.24.1 Company details
11.24.2 Financial outlook
11.24.3 Product summary
11.24.4 Recent developments
11.25 Respan Products Inc.
11.25.1 Company details
11.25.2 Financial outlook
11.25.3 Product summary
11.25.4 Recent developments
11.26 Smiths Medical
11.26.1 Company details
11.26.2 Financial outlook
11.26.3 Product summary
11.26.4 Recent developments
11.27 Taiyo Nippon Sanso Corporation
11.27.1 Company details
11.27.2 Financial outlook
11.27.3 Product summary
11.27.4 Recent developments
11.28 Tecno-Gaz Industries
11.28.1 Company details
11.28.2 Financial outlook
11.28.3 Product summary
11.28.4 Recent developments
11.29 Teleflex Incorporated
11.29.1 Company details
11.29.2 Financial outlook
11.29.3 Product summary
11.29.4 Recent developments
11.30 Weinmann Emergency Medical Technology GmbH + Co. KG
11.30.1 Company details
11.30.2 Financial outlook
11.30.3 Product summary
11.30.4 Recent developments